During the recent session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 2.49 million, with the beta value of the company hitting 2.18. At the last check today, the stock’s price was $1.69, reflecting an intraday loss of -5.06% or -$0.09. The 52-week high for the CDT share is $392.00, that puts it down -23095.27 from that peak though still a striking 14.2% gain since the share price plummeted to a 52-week low of $1.45. The company’s market capitalization is $3.59M, and the average intraday trading volume over the past 10 days was 16.1 million shares, and the average trade volume was 3.24 million shares over the past three months.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Conduit Pharmaceuticals Inc (CDT) registered a -5.06% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -5.06% in intraday trading to $1.69, hitting a weekly high. The stock’s 5-day price performance is 9.03%, and it has moved by -81.63% in 30 days. Based on these gigs, the overall price performance for the year is -99.39%. The short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) is 3.57 million shares and it means that shorts have 0.14 day(s) to cover.

CDT Dividends

Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Conduit Pharmaceuticals Inc (CDT) shares are Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund. Data provided on Oct 31, 2024 indicates that Fidelity Small Cap Index Fund owns about 2.33 shares. This amounts to just over 0.13 percent of the company’s overall shares, with a $3900.0 market value. The same data shows that the other fund manager holds slightly less at 2.03, or about 0.11% of the stock, which is worth about $3391.0.